匯鴻集團(600981.SH):匯鴻創投將因華泰大健康基金淨值變化增加公允價值變動損益5045.54萬元
格隆匯 1 月 27日丨匯鴻集團(600981.SH)公佈,近日,公司全資子公司匯鴻創投收到華泰大健康執行事務合夥人華泰紫金投資有限責任公司提供的華泰大健康基金2020年度未經審計的財務報表,華泰大健康基金淨資產有所增長。
根據《企業會計準則》相關規定,根據金融工具確認和計量的會計政策進行計量,匯鴻創投將因華泰大健康基金淨值變化增加公允價值變動損益5045.54萬元,對公司2020年度當期損益預計產生影響5045.54萬元。華泰大健康基金財務報表尚未經過審計。以上數據未經公司年審會計師事務所審計,僅為公司財務部門預計數。
華泰大健康基金的投資標的持有至解禁後的股價波動存在不確定性,未來預期收益存在不確定性,對基金淨資產產生影響,進而影響公司損益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.